Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glycosylation of mammalian proteins is known to influence their intracellular trafficking, half life, and susceptibility to enzymatic degradation. Rare instances of natural T cell epitopes dependent upon glycosylation for recognition have been described. We report here on human CD4(+) T lymphocyte cultures and clones from two melanoma patients that recognize the melanoma-associated Ag
tyrosinase
in the context of HLA-DR4 and -
DR8
. These T cells recognize
tyrosinase
, normally a heavily glycosylated molecule, when expressed constitutively in melanoma cells or in COS-7 transfectants pulsed as lysates onto autologous APC. However, these T cells fail to recognize
tyrosinase
expressed in bacteria, nor do they react with overlapping peptides covering full-length
tyrosinase
, suggesting a critical role for glycosylation in the processing and / or composition of the stimulatory epitopes. The requirement for glycosylation was demonstrated by the failure of
tyrosinase
-specific CD4(+) T cells to recognize
tyrosinase
synthesized in the presence of glycosylation inhibitors, or deglycosylated enzymatically. Site-directed mutagenesis of each of seven potential N-glycosylation sites showed that four sites were required to generate forms of
tyrosinase
that could be recognized by individual T cell clones. These data indicate that certain carbohydrate moieties are required for processing the
tyrosinase
peptides recognized by CD4(+) T cells. Post-translational modifications of human tumor-associated proteins such as
tyrosinase
could be a critical factor for the development of antitumor immune responses.
...
PMID:N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells. 1153 67